South East Water faces £22m fine for supply failures

The government had hit business too hard when it raised employers’ National Insurance contributions in autumn 2024, followed by bigger than expected rises to minimum wage rates, and new employment rights, which had deterred businesses from hiring, investing and growing, he said.

The maker of Wegovy and Ozempic, Novo Nordisk, has announced it will cut 9,000 jobs weeks after warning that profits will fall as more “knock-off” weight-loss drugs emerge. The redundancies make up 11% of the Danish company’s workforce and mark the first major step by new chief executive Mike Doustdar as Novo Nordisk faces mounting…

The company behind weight-loss jab Wegovy and diabetes drug Ozempic will have a boardroom clear-out, with seven board members including the chairman set to depart. Novo Nordisk on Tuesday said chairman Helge Lund, vice chair Henrik Poulsen and five directors will not stand for re-election at an extraordinary investor meeting in November. The departures came…